Licarbazepine
CAS No. 29331-92-8
Licarbazepine ( Licarbazepine;?1011-hydroxy-1011 Dihydrocarbamezer )
产品货号. M21077 CAS No. 29331-92-8
Licarbazepine is the pharmacologically active metabolite of oxcarbazepine a drug indicated for the treatment of partial seizures and bipolar disorders.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
50MG | ¥786 | 有现货 |
|
100MG | ¥988 | 有现货 |
|
200MG | ¥1442 | 有现货 |
|
500MG | 获取报价 | 有现货 |
|
1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Licarbazepine
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Licarbazepine is the pharmacologically active metabolite of oxcarbazepine a drug indicated for the treatment of partial seizures and bipolar disorders.
-
产品描述Licarbazepine is the pharmacologically active metabolite of oxcarbazepine a drug indicated for the treatment of partial seizures and bipolar disorders.
-
同义词Licarbazepine;?1011-hydroxy-1011 Dihydrocarbamezer
-
通路Others
-
靶点Other Targets
-
受体Others
-
研究领域Neurological Disease
-
适应症Bipolar Disorder
化学信息
-
CAS Number29331-92-8
-
分子量254.28
-
分子式C15H14N2O2
-
纯度>98% (HPLC)
-
溶解度DMSO:3mg/ml(11.7mM)
-
SMILESNC(=O)N1c2ccccc2CC(O)c2ccccc21
-
化学全称10-hydroxy-1011-dihydro-5H-dibenzo[bf]azepine-5-carboxamide
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Begas E Tsakalof A Dardiotis E et al. Development and validation of a reversed-phase HPLC method for licarbazepine monitoring in serum of patients under oxcarbazepine treatment: HPLC method for licarbazepine monitoring in serum of patients[J]. Biomedical Chromatography 2017 31(9).
产品手册
关联产品
-
N-Benzyloleamide
N-(3-Methoxybenzyl)Oleamide, an agmatine isolated from Lepidium meyenii, has pharmacological effects on exercise-induced fatigue, which may be related to the modulation of energy metabolism and improvement of antioxidant status.
-
Methyl nomilinate
Methyl nomilinate from citrus can modulate cell cycle regulators to induce cytotoxicity in human colon cancer (SW480) cells in vitro.
-
Cuminaldehyde
Cuminaldehyde is a natural aldehyde with inhibitory effect on alpha-synuclein fibrillation and cytotoxicity.?